Ridgefield, CT30+ days ago
Support the implementation of scientifically robust non-clinical safety strategies, spanning from NTC discovery through clinical trial execution to regulatory submission for marketing authorization, specifically for the development of intravitreal (IVT) medications in eye health across various modalities, ensuring alignment with external requirements and benchmark project strategies. Your role includes advising on all aspects of nonclinical safety for new drugs of different Modalities—covering the nonclinical testing strategy, study design, dose selection, and the overall toxicological assessments—and supporting the preparation of development plans, protocols, reports, and regulatory documents.